Pfizer Confident On Policy Outlook Heading Into Trump Administration

 
• By Jessica Merrill

The company updated investors on its 2025 financial guidance and a recent meeting with incoming US president Trump and HHS secretary nominee Robert F. Kennedy, Jr.

(Shutterstock)

More from Earnings

More from Drug Pricing